Work

Older age as a predictor of post-transplant survival in newly diagnosed acute myeloid leukemia treated with HMA-venetoclax.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6530

Authors: Momna Warraich, Sudhesh Kumar, Mahnoor Fatima, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Antoine N. Saliba, Aasiya Matin, Mark Robert Litzow, William J. Hogan, Mithun Vinod Shah, Animesh Dev Pardanani, James M. Foran, Lisa Sproat, Nandita Khera, Ayalew Tefferi, Naseema Gangat

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162561400

Cites:

Cited by:

Related to: